- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02340793
BEYOND Weight Loss Study (BEYOND)
Body Composition and Energy Expenditure With Total Diet Replacement During Weight Loss and Maintenance
National guidelines recommend 15-20% weight loss for severe and complicated obesity. Weight loss maintenance can be achieved in around 33% of patients at 12 months.
The BEYOND study will administer Counterweight Plus; a nutritionally replete Total Diet Replacement Plan (TDR) of 800+ Calories followed by structured Food Reintroduction, and Weight Loss Maintenance programmes.
The study will incorporate three work packages with the aim of:
- examining changes in body composition with substantial (target >15kg) non-surgical weight loss (work package 1, WP1)
- characterizing the metabolic adaptations during weight loss and maintenance (work package 2, WP2)
- examining Rescue Packages as a method of weight re-gain prevention (work package 3, WP3).
Study Overview
Detailed Description
All participants will receive the Counterweight Plus dietary intervention. This consists of:
- 12-20 weeks 800+ calories/day Total Diet Replacement Plan, followed by
- 6-8 weeks Food Reintroduction, followed by
- up to 104 weeks Weight Loss Maintenance, based on maintaining daily calorie restriction.
All participants will undergo the following investigations at baseline and at regular intervals throughout the study period:
- height (baseline only)
- whole body MRI scans: total-body skeletal muscle volume and fat mass will be measured using whole-body multi-slice MRI (baseline and 12 weeks only)
- functional assessment: completion of the Western Ontario and McMaster Universities Arthritis Index (WOMAC) (baseline and 12 weeks only)
- gait and muscle strength assessment: biomechanical gait analysis will be carried out using an 8 camera VICON system during flat walking to determine maximum flexion and extension moments for both limbs and maximum adduction and abduction moments. Muscle strength will also be directly measured of both the upper (grip strength) and lower (quadriceps and hamstrings) limb using a dynamometer and myometer (baseline and 12 weeks only)
- anthropometric measurement: body weight; waist, hip, thigh, arm and calf circumferences
- indirect calorimetry: resting metabolic rate will be measured by a computerised open-circuit ventilated hood system
- fasting blood sampling: for measurement of HbA1C, lipid profile, leptin, thyroid hormones
- gut microbiota analysis from faecal samples
- Binge Eating Disorder and Quality of Life (EQ-5D) questionnaires
Participants will receive regular support/advice from a research dietician/ nutritionist during the two year study period.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Scotland
-
Glasgow, Scotland, United Kingdom, G31 2ER
- Glasgow Royal Infirmary
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- confirmation from general practitioner (GP) of suitability for intervention
- written informed consent
- female
- BMI ≥30 kg/m2 and < 45kg/m2, weight<200 kg and <60 cm bore size
Exclusion Criteria:
- known illness such as heart disease, cancer, or any disability that would affect weight loss (diabetes not an exclusion) or prevent completion of the intervention
- implanted electronic devices that are MRI incompatible or MRI unsafe, ferromagnetic foreign bodies
- substance abuse
- myocardial infarction within previous 6 months
- learning difficulties and subjects having difficulty in understanding verbal or written English
- pregnant/ considering pregnancy
- patients who have required hospitalisation for depression or are on antipsychotic drugs
- people currently participating in another clinical research trial
- recent weight loss >5kg within the last 6 months
- current treatment with anti-obesity drugs
- diagnosed eating disorder
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Counterweight Plus Dietary Intervention
Weight management programme including total diet replacement with soups and shakes; approximately 800 calories/day
|
A non-surgical, nutritionally replete weight management programme comprising a Total Diet Replacement Plan (TDR) of 800+ calories/day to produce a weight loss of >15kg over 12-20 weeks; followed by a structured Food Reintroduction phase for 6-8 weeks and a Weight Loss Maintenance phase; total intervention period 2 years.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
WP1: change in body composition with substantial, non-surgical, weight loss
Time Frame: 20 weeks
|
Measurement of muscle mass before and after a weight loss programme using MRI
|
20 weeks
|
|
WP1: change in body composition with substantial, non-surgical, weight loss
Time Frame: 20 weeks
|
Measurement of fat mass before and after a weight loss programme using MRI
|
20 weeks
|
|
WP2: metabolic adaptation during weight loss and maintenance
Time Frame: 2 years
|
Change in resting metabolic rate before and after weight loss
|
2 years
|
|
WP3: weight regain prevention
Time Frame: 2 years
|
% achieving >15kg weight loss at 12 and 24 months
|
2 years
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Muscle/fat mass of specific muscle groups
Time Frame: 20 weeks
|
Relationship between predicted muscle and fat mass with the strength of specific muscle groups (by muscle strength, gait analysis and WOMAC questionnaire)
|
20 weeks
|
|
Adherence and acceptability of Rescue Packages to Patients
Time Frame: 2 years
|
Number of participants requiring and completing rescue packages
|
2 years
|
|
Metabolic adaptive effect of weight loss
Time Frame: 2 years
|
Comparison of leptin, ghrelin and thyroid hormone levels at baseline to those during weight loss and maintenance to establish
|
2 years
|
|
Weight regain prevention
Time Frame: 2 years
|
changes in BED Questionnaire Rating Score
|
2 years
|
|
Weight regain prevention
Time Frame: 2 years
|
% undertaking Rescue Package during Weight Loss Maintenance
|
2 years
|
|
Weight regain prevention
Time Frame: 2 years
|
rate of weight regain during Weight Loss Maintenance
|
2 years
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Michael EJ Lean, MA MB BChir MD, University of Glasgow
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- GN14RA448
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.